Alyeska Investment Group
SBRA icon

Alyeska Investment Group’s Sabra Healthcare REIT SBRA Stock Holding History

Alyeska Investment Group’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-98,974
Closed -$1.9M – 777
2026
Q1 		$1.9M Buy
+98,974
New +$1.95M 0.01% 549
2015
Q1 		– Sell
-258,641
Closed -$7.86M – 570
2014
Q4 		$7.86M Buy
258,641
+65,421
+34% +$1.8M 0.13% 231
2014
Q3 		$4.7M Buy
193,220
+69,556
+56% +$1.93M 0.1% 230
2014
Q2 		$3.55M Buy
+123,664
New +$3.59M 0.08% 263

Other funds holding SBRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CIM
Centersquare Investment Management Conshohocken, Pennsylvania $11.7B AUM 20.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Alyeska Investment Group's SBRA Position: Q2 2026 in Review

Alyeska Investment Group sold out of Sabra Healthcare REIT (SBRA) in Q2 2026, closing a stake of 98,974 shares — an estimated $1.9M sold.

Alyeska Investment Group first reported a position in SBRA in Q2 2014 and held it in 4 quarters. The position peaked at $7.86M in Q4 2014. 466 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Alyeska Investment Group reported no remaining Sabra Healthcare REIT position as of Q2 2026 after selling out during the quarter.
  • Alyeska Investment Group sold 98,974 Sabra Healthcare REIT shares in Q2 2026, an estimated $1.9M.
  • Alyeska Investment Group first reported a position in Sabra Healthcare REIT in Q2 2014 and held it in 4 quarters.
  • Alyeska Investment Group's Sabra Healthcare REIT position peaked at $7.86M in Q4 2014.
  • 466 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.